Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone
- 23 October 2015
- journal article
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 12 (6) , 695-701
Abstract
Objective: Hepcidin-25 production is stimulated by systemic inflammation, and it interferes with iron utilization, leading to anemia. This study aimed to investigate the relationships between the p...Keywords
This publication has 29 references indexed in Scilit:
- Identification of erythroferrone as an erythroid regulator of iron metabolismNature Genetics, 2014
- Hepcidin and iron homeostasisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- HEPCIDIN, ANAEMIA, AND PROSTATE CANCERBJU International, 2011
- In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2Blood, 2010
- Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinomaBMC Cancer, 2009
- Immunoassay for human serum hepcidinBlood, 2008
- A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral ironHaematologica, 2008
- Cancer-related anemia and recombinant human erythropoietin—an updated overviewNature Clinical Practice Oncology, 2006
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004
- IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidinJournal of Clinical Investigation, 2004